Topics:
February 16, 2021
Over the course of the pandemic, Cigna has taken bold actions to remove uncertainty and make health care easier offering peace of mind to all of those we serve. As COVID-19 vaccine availability increases, we are moving to normalize benefits to further our mission of affordable, predictable, and simple health care for all of our customers and plan sponsors.
Cigna’s customer cost-share waiver program for COVID-19 treatment is set to conclude on Feb. 15, 2021. Our customers will continue to have $0 cost sharing for all FDA-approved COVID-19 vaccines and diagnostic COVID-19 testing and related screening office or virtual visit, as required by the CARES Act.
It’s important to underscore our ongoing commitment to help ensure our customers have access to COVID-19-related services, support, and treatment, including:
Continue to Encourage Prevention
Even after vaccination, it’s important to continue encouraging your workforce to follow CDC guidelines to help prevent exposure to COVID-19. This includes:
These practices have definitively shown to decrease the spread of COVID-19 and other viruses like the flu.
As we have done throughout this pandemic, we will continue to evaluate the course of the disease and make adjustments to our policy decisions when appropriate. Thank you for your trust. Together, we will overcome this pandemic.
We’d be happy to have your join our team of independent agents.
JOIN NOW